TY - JOUR
T1 - Protocol for a multi-site, cluster‐randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non‐small‐cell lung cancer
T2 - the ENSURE-GA study
AU - Tsubata, Yukari
AU - Shinomiya, Shun
AU - Inoue, Koji
AU - Ishikawa, Nobuhisa
AU - Saito, Ryota
AU - Nakashima, Kazuhisa
AU - Hotta, Katsuyuki
AU - Hamada, Akinobu
AU - Nagashima, Fumio
AU - Ando, Yuichi
AU - Morita, Satoshi
AU - Kobayashi, Kunihiko
AU - Isobe, Takeshi
N1 - Funding Information:
All data is supported by and stored on the portal site of the Practical Research for Innovative Cancer Control Management Office created by the Japan Cancer Research Project, one of the projects promoted by the Japan Agency for Medical Research and Development, https://portal.jcrp-primo.jp/ .
Funding Information:
This study is being funded by the Japan Agency for Medical Research and Development (grant number: 19ck0106512h001). The funding body is not involved in the protocol development or research promotion advice, nor is it involved in the interpretation of the results.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: In Japan, approximately half of all lung cancer patients are aged > 75 years, and the proportion of older patients is increasing. In older patients, it is necessary to consider comorbidities and concomitant drug use to ensure optimal cancer treatment; however, geriatric assessment (GA) is not widely performed. We plan to conduct a study (ENSURE-GA) of GA in older lung cancer patients to determine whether GA with intervention improves patient satisfaction with their treatment. Methods: The study will be a phase III comparative clinical trial with a cluster-randomized design, and it will be conducted at 81 sites distributed throughout Japan. Approximately 1000 lung cancer patients aged ≥ 75 years will be enrolled in the study. All participants will undergo a standardized GA before starting treatment (using an iPad). At the intervention sites, the GA results and intervention method recommended on the basis of the GA results will be returned as an instant report to guide the physician’s choice of intervention. At the control sites, the physician will decide on interventions based on standard practice. All participants will complete a patient satisfaction survey before treatment initiation (after the GA) and 3 months later. Discussion: The purpose of the ENSURE-GA study is to evaluate whether GA with interventions improves patient satisfaction with treatment outcomes. The study may lead to the increased use of GA and improved treatment of cancer in older adults. The results will also be used to prepare guidelines for treating older cancer patients and will provide a foundation for the development of a standardized geriatric oncology system. Trial registration: The study has been registered in the University Hospital Medical Information Network database (no. UMIN000037590). The registration date is August 4, 2019, and the protocol version is 2.0. (https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000042853.)
AB - Background: In Japan, approximately half of all lung cancer patients are aged > 75 years, and the proportion of older patients is increasing. In older patients, it is necessary to consider comorbidities and concomitant drug use to ensure optimal cancer treatment; however, geriatric assessment (GA) is not widely performed. We plan to conduct a study (ENSURE-GA) of GA in older lung cancer patients to determine whether GA with intervention improves patient satisfaction with their treatment. Methods: The study will be a phase III comparative clinical trial with a cluster-randomized design, and it will be conducted at 81 sites distributed throughout Japan. Approximately 1000 lung cancer patients aged ≥ 75 years will be enrolled in the study. All participants will undergo a standardized GA before starting treatment (using an iPad). At the intervention sites, the GA results and intervention method recommended on the basis of the GA results will be returned as an instant report to guide the physician’s choice of intervention. At the control sites, the physician will decide on interventions based on standard practice. All participants will complete a patient satisfaction survey before treatment initiation (after the GA) and 3 months later. Discussion: The purpose of the ENSURE-GA study is to evaluate whether GA with interventions improves patient satisfaction with treatment outcomes. The study may lead to the increased use of GA and improved treatment of cancer in older adults. The results will also be used to prepare guidelines for treating older cancer patients and will provide a foundation for the development of a standardized geriatric oncology system. Trial registration: The study has been registered in the University Hospital Medical Information Network database (no. UMIN000037590). The registration date is August 4, 2019, and the protocol version is 2.0. (https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000042853.)
KW - Cancer treatment
KW - Cluster‐randomized trial
KW - Geriatric assessment
KW - Lung cancer
KW - Patient satisfaction
UR - http://www.scopus.com/inward/record.url?scp=85099947643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099947643&partnerID=8YFLogxK
U2 - 10.1186/s12877-021-02028-w
DO - 10.1186/s12877-021-02028-w
M3 - Article
C2 - 33482741
AN - SCOPUS:85099947643
SN - 1471-2318
VL - 21
JO - BMC Geriatrics
JF - BMC Geriatrics
IS - 1
M1 - 74
ER -